Effectiveness of the Use of Lightback in Conventional Football Training.

Effectiveness of the Use of Lightback in Conventional Football Training. Randomised Clinical Trial.

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT06490354

Enrollment

Registered

2024-07-08

Start date

2024-07-01

Completion date

2025-03-24

Last updated

2025-03-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Injury; Hip

Keywords

hip, gluteal regions, range of motion, articular, footballs

Brief summary

Lightback is a patented device that allows instrumental stretching of the gluteal muscles. Football players overload this musculature and this type of device is effective and the cost/benefit ratio is high. The intention is to carry out a randomised clinical trial to carry out a study on athletes to see the differences between a group of football players with their normal training and a group of football players with their normal training and the application of lightback beforehand. The variables studied will be sprint speed in 20 and 40m, vertical jump height, hamstring muscle injuries throughout the season, triceps sural injuries throughout the season, internal and external hip ROM, dorsal flexion ankle ROM.

Interventions

DEVICELightback group

Use of the patented Lightback device to relax the gluteal musculature and prevent hamstring injuries.

OTHERConventional treatment

Conventional treatment to relax the gluteal musculature and prevent hamstring injuries.

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

SINGLE (Investigator)

Masking description

Single blinding.

Eligibility

Sex/Gender

ALL

Age

18 Years to 45 Years

Healthy volunteers

Inclusion criteria

* Professional football players * Age range 18 to 45 years * Able to perform physical exertion without discomfort.

Exclusion criteria

* Football players recently injured or in an active recovery phase. * Heterometrics * Non-collaborators * Alteration of sensitivity

Design outcomes

Primary

Measure	Time frame	Description
Range of motion	5 weeks	Measurement of hip joint range and ankle dorsiflexion measured with goniometer

Secondary

Measure	Time frame	Description
Sprint	5 weeks	Measurement of speed over 20 and 40 metres using approved devices
Vertical jump height	5 weeks	Measurement of height (metres) using approved devices

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026